What's in DH Bio Co., Ltd.'s pipeline?

DH Bio Co., Ltd. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with DH Bio Co., Ltd.'s portfolio?

Top competitors by shared drug class: Palvella Therapeutics, Inc., Aevi Genomic Medicine, LLC, a Cerecor company, Aptarion Biotech AG, Amorphical Ltd., Angitia Incorporated Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dh-bio-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

DH Bio Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DH Bio Co., Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Haporine-S	Haporine-S	phase 3	PI3K inhibitor	PI3K	Oncology
Restasis (cyclosporine 0.05%)	Restasis (cyclosporine 0.05%)	phase 3	immunosuppressant	calcineurin	Ophthalmology

Therapeutic area mix

Oncology · 1
Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Palvella Therapeutics, Inc. · 2 shared drug classes
Aevi Genomic Medicine, LLC, a Cerecor company · 1 shared drug class
Aptarion Biotech AG · 1 shared drug class
Amorphical Ltd. · 1 shared drug class
Angitia Incorporated Limited · 1 shared drug class
Applied Biology, Inc. · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Addpharma Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for DH Bio Co., Ltd.:

Cite this brief

Drug Landscape (2026). DH Bio Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dh-bio-co-ltd. Accessed 2026-05-16.